News

In line with broadening geography of pharma markets, W-K ‘glocalizes’ its services

Vetter and Sentry BioPharma Services establish preferred partnership agreement

No specific guidelines included on how restrictive financial interactions should be

FDA-run website will provide a single point of reference

Gaps found in gray areas like adverse events reported on blogs and interactive web events

PPACA provides $3 billion in funding and creates new Patient-Centered Outcomes Research Institute

Service builds on ValueCentrics’ ValueTrak channel-data tracking capability

Singapore-based Clearstate will help UBC clients navigate complex reimbursements policies

Altegrity Risk International named security partner in Closed-Loop Protection Program

Specialty pharmacy wins $61.5M in tax credits and $14M in grants for 1,000-plus jobs

‘Pharmerging’ markets will provide half the boost to 2014’s $1.1-trillion market

Blockbusters Lipitor and Plavix disappear from list due to patent expirations

90-day supplies and lower out-of-pocket expenses positively impact compliance

Reformulated drug is a ‘step in the right direction,’ says FDA director

CDC to release action plan for dealing with unused or expired swine flu vaccine

CMS will be changing reimbursement practices regardless of how healthcare reform plays out

Industry anticipates meaningful guidance from FDA on use of social media

Investment funds have developed an interest in trading capital for royalties on drug commercializations

Business, regulatory and technological conditions are constantly changing. Will your CRM/SFA system be flexible enough to keep up?

Multi-tenant sales-force automation (SFA) systems are coping with an increasingly complex regulatory environment

Converging the processes and data from EHRs and from the electronic data-capture (EDC) of the clinical research environment could change the paradigm of drug development and safety

Parenteral (injectable) drugs gain user acceptance even as biotech brings more of them onto the market

The growth of healthcare business is attracting many new players to the pharmaceutical arena, challenging pharma’s relationships with patients